Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 450

Similar articles for PubMed (Select 15827332)

1.

Parthenolide and sulindac cooperate to mediate growth suppression and inhibit the nuclear factor-kappa B pathway in pancreatic carcinoma cells.

Yip-Schneider MT, Nakshatri H, Sweeney CJ, Marshall MS, Wiebke EA, Schmidt CM.

Mol Cancer Ther. 2005 Apr;4(4):587-94.

2.

MEK inhibition of pancreatic carcinoma cells by U0126 and its effect in combination with sulindac.

Yip-Schneider MT, Schmidt CM.

Pancreas. 2003 Nov;27(4):337-44.

PMID:
14576498
3.

Parthenolide cooperates with NS398 to inhibit growth of human hepatocellular carcinoma cells through effects on apoptosis and G0-G1 cell cycle arrest.

Ralstin MC, Gage EA, Yip-Schneider MT, Klein PJ, Wiebke EA, Schmidt CM.

Mol Cancer Res. 2006 Jun;4(6):387-99.

4.

Suppression of pancreatic tumor growth by combination chemotherapy with sulindac and LC-1 is associated with cyclin D1 inhibition in vivo.

Yip-Schneider MT, Wu H, Ralstin M, Yiannoutsos C, Crooks PA, Neelakantan S, Noble S, Nakshatri H, Sweeney CJ, Schmidt CM.

Mol Cancer Ther. 2007 Jun;6(6):1736-44. Epub 2007 May 31. Erratum in: Mol Cancer Ther. 2007 Oct;6(10):2816.

5.

A novel combination therapy with arsenic trioxide and parthenolide against pancreatic cancer cells.

Wang W, Adachi M, Zhang R, Zhou J, Zhu D.

Pancreas. 2009 May;38(4):e114-23. doi: 10.1097/MPA.0b013e3181a0b6f2.

PMID:
19342982
6.

Sesquiterpene lactone parthenolide suppresses tumor growth in a xenograft model of renal cell carcinoma by inhibiting the activation of NF-kappaB.

Oka D, Nishimura K, Shiba M, Nakai Y, Arai Y, Nakayama M, Takayama H, Inoue H, Okuyama A, Nonomura N.

Int J Cancer. 2007 Jun 15;120(12):2576-81.

PMID:
17290398
7.

Suppression of NF-kappaB activity by parthenolide induces X-ray sensitivity through inhibition of split-dose repair in TP53 null prostate cancer cells.

Watson C, Miller DA, Chin-Sinex H, Losch A, Hughes W, Sweeney C, Mendonca MS.

Radiat Res. 2009 Apr;171(4):389-96. doi: 10.1667/RR1394.1.

PMID:
19397439
8.

Dimethylamino parthenolide enhances the inhibitory effects of gemcitabine in human pancreatic cancer cells.

Holcomb BK, Yip-Schneider MT, Waters JA, Beane JD, Crooks PA, Schmidt CM.

J Gastrointest Surg. 2012 Jul;16(7):1333-40. doi: 10.1007/s11605-012-1913-7. Epub 2012 May 23.

PMID:
22618517
9.
11.

Inactivation of NF-kappaB by 3,3'-diindolylmethane contributes to increased apoptosis induced by chemotherapeutic agent in breast cancer cells.

Rahman KM, Ali S, Aboukameel A, Sarkar SH, Wang Z, Philip PA, Sakr WA, Raz A.

Mol Cancer Ther. 2007 Oct;6(10):2757-65. Epub 2007 Oct 3.

12.

Antimyeloma effects of a sesquiterpene lactone parthenolide.

Suvannasankha A, Crean CD, Shanmugam R, Farag SS, Abonour R, Boswell HS, Nakshatri H.

Clin Cancer Res. 2008 Mar 15;14(6):1814-22. doi: 10.1158/1078-0432.CCR-07-1359.

13.

Inhibition of the phosphatidylinositol 3'-kinase signaling pathway increases the responsiveness of pancreatic carcinoma cells to sulindac.

Yip-Schneider MT, Wiesenauer CA, Schmidt CM.

J Gastrointest Surg. 2003 Mar-Apr;7(3):354-63.

PMID:
12654560
14.

Sesquiterpene lactone parthenolide markedly enhances sensitivity of human A549 cells to low-dose oxaliplatin via inhibition of NF-kappaB activation and induction of apoptosis.

Fang LJ, Shao XT, Wang S, Lu GH, Xu T, Zhou JY.

Planta Med. 2010 Feb;76(3):258-64. doi: 10.1055/s-0029-1186083. Epub 2009 Sep 11.

PMID:
19774508
15.

Salicylates inhibit NF-kappaB activation and enhance TNF-alpha-induced apoptosis in human pancreatic cancer cells.

McDade TP, Perugini RA, Vittimberga FJ Jr, Carrigan RC, Callery MP.

J Surg Res. 1999 May 1;83(1):56-61.

PMID:
10210643
16.

Cisplatin-induced antitumor activity is potentiated by the soy isoflavone genistein in BxPC-3 pancreatic tumor xenografts.

Mohammad RM, Banerjee S, Li Y, Aboukameel A, Kucuk O, Sarkar FH.

Cancer. 2006 Mar 15;106(6):1260-8.

17.

Combination of tumor necrosis factor-alpha with sulindac in human carcinoma cells in vivo.

Yasui H, Adachi M, Imai K.

Ann N Y Acad Sci. 2003 Dec;1010:273-7.

PMID:
15033733
18.

Indirubin enhances tumor necrosis factor-induced apoptosis through modulation of nuclear factor-kappa B signaling pathway.

Sethi G, Ahn KS, Sandur SK, Lin X, Chaturvedi MM, Aggarwal BB.

J Biol Chem. 2006 Aug 18;281(33):23425-35. Epub 2006 Jun 19.

19.

Sulindac enhances tumor necrosis factor-alpha-mediated apoptosis of lung cancer cell lines by inhibition of nuclear factor-kappaB.

Berman KS, Verma UN, Harburg G, Minna JD, Cobb MH, Gaynor RB.

Clin Cancer Res. 2002 Feb;8(2):354-60.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk